Evaluating the Total Costs of Chemotherapy-Induced Febrile Neutropenia: Results from a Pilot Study with Community Oncology Cancer Patients-Reference-Cited by-同舟云学术

Evaluating the Total Costs of Chemotherapy-Induced Febrile Neutropenia: Results from a Pilot Study with Community Oncology Cancer Patients

Published:2007-04-01 Issue:4 Volume:12 Page:478-483
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Bennett Charles L.¹,Calhoun Elizabeth A.²

Affiliation:

1. a The Robert H. Lurie Comprehensive Cancer Center and the Division of Hematology/Oncology, Northwestern University, Chicago, Illinois, USA

2. b University of Illinois School of Public Health, Chicago, Illinois, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Discuss the definitions of direct and indirect costs of medical care.Describe the feasibility of obtaining information on direct and indirect medical costs associated with febrile neutropenia.Identify clinical and nonclinical factors that are associated with larger estimates of direct and indirect medical costs for febrile neutropenia. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Funder

Amgen

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-4-478

Reference23 articles.

1. Cost-utility assessment of amifostine as first-line therapy for ovarian cancer;Bennett;Int J Gynecol Cancer,1998

2. The burden of illness of cancer: Economic cost and quality of life;Brown;Annu Rev Public Health,2000

3. Cost of care for cancer in a health maintenance organization;Fireman;Health Care Financ Rev,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States;Value in Health;2024-02

2. Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices;Cancer Medicine;2023-03-31

3. Efficacy of Ciprofloxacin in Prevention of Sepsis Among the Patients with Chemotherapy-Induced Neutropenia: A Randomized Double-Blind Clinical Trial in a University Hospital in Tehran, Iran;Annals of Military and Health Sciences Research;2022-09-06

4. Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?;The Oncologist;2022-05-12

5. Trilaciclib and the economic value of multilineage myeloprotection from chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer treated with first-line chemotherapy;Journal of Medical Economics;2021-11-16